SCHEMBL20767153

SCHEMBL20767153

CNS(=O)(=O)c1ccc(NC2CCCCC2)c(-c2cn(C3CC3)cn2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
YAP1 P46937 2/20 0.43
TEAD1 P28347 1/20 0.43
BRD4 O60885 4/20 0.42
ALOX15 P16050 1/20 0.38
SYK P43405 2/20 0.38
CHEK1 O14757 1/20 0.37
NTRK1 P04629 1/20 0.37
MET P08581 1/20 0.37
PIM1 P11309 1/20 0.37
LTK P29376 1/20 0.37
GRK5 P34947 1/20 0.37
MAP2K2 P36507 1/20 0.37
CDK8 P49336 1/20 0.37
NEK2 P51955 1/20 0.37
LIMK1 P53667 1/20 0.37
TYRO3 Q06418 1/20 0.37
MAP4K2 Q12851 1/20 0.37
DYRK1A Q13627 1/20 0.37
AURKB Q96GD4 1/20 0.37
S1PR1 P21453 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20766526 0.87 YAP1 (0.57) YAP1TEAD1BRD4ALOX15SYK
SCHEMBL20767465 0.84 YAP1 (0.43) YAP1TEAD1BRD4ALOX15SYK
SCHEMBL20766444 0.84 YAP1 (0.43) YAP1TEAD1BRD4ALOX15SYK
SCHEMBL20767361 0.80 BRD4 (0.43) YAP1TEAD1BRD4ALOX15SYK
SCHEMBL20766351 0.80 GPR39 (0.47) YAP1BRD4ALOX15TYRO3KDM4E
SCHEMBL20766974 0.80 BRD4 (0.45) YAP1TEAD1BRD4ALOX15SYK
SCHEMBL30411184 0.80 GPR39 (0.47) YAP1BRD4ALOX15TYRO3KDM4E
SCHEMBL20779876 0.80 ALDH1A1 (0.32) BRD4KDM4ELMNAALDH1A1
SCHEMBL20766185 0.79 SCN9A (0.43) YAP1BRD4ALOX15S1PR1S1PR3
SCHEMBL20766828 0.78 ALOX15 (0.44) YAP1BRD4ALOX15CHEK1NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111542315-B Benzosulfonyl compounds 维瓦斯治疗公司 2023-05-12 CN disclosed
EP-3691623-B1 BENZOSULFONYL COMPOUNDS VIVACE THERAPEUTICS INC (US) 2022-10-05 EP disclosed
US-11192865-B2 Benzosulfonyl compounds VIVACE THERAPEUTICS, INC. (US) 2021-12-07 US disclosed
US-11192865-B2 Benzosulfonyl compounds VIVACE THERAPEUTICS, INC. (US) 2021-12-07 US disclosed
US-20200354325-A1 BENZOSULFONYL COMPOUNDS VIVACE THERAPEUTICS, INC. 2020-11-12 US disclosed
US-20200354325-A1 BENZOSULFONYL COMPOUNDS VIVACE THERAPEUTICS, INC. 2020-11-12 US disclosed
CN-111542315-A Benzosulfonyl compounds 维瓦斯治疗公司 2020-08-14 CN disclosed
EP-3691623-A1 BENZOSULFONYL COMPOUNDS Vivace Therapeutics, Inc. (US) 2020-08-12 EP disclosed
WO-2019040380-A1 BENZOSULFONYL COMPOUNDS VIVACE THERAPEUTICS, INC. (US) 2019-02-28 WO disclosed
WO-2019040380-A1 BENZOSULFONYL COMPOUNDS VIVACE THERAPEUTICS, INC. (US) 2019-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192865-B2 Benzosulfonyl compounds YAP1, TEAD2, TEAD1 YAP1 1/4885TEAD1 3/4885BRD4 7/4885
US-20200354325-A1 BENZOSULFONYL COMPOUNDS YAP1, TEAD2, TEAD1 YAP1 1/4885TEAD1 3/4885BRD4 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.